Late last week, Regeneron Pharmaceuticals, Inc. filed an antitrust complaint against Amgen Inc. in the U.S. District Court for the District of Delaware. Regeneron alleges that “Amgen is engaged in a persistent exclusionary...more
In a much anticipated opinion, the U.S. Court of Appeals for the Ninth Circuit reversed a California district court decision holding that Qualcomm violated U.S. antitrust laws in its licensing of standard-essential patents in...more
8/12/2020
/ 5G Network ,
Anti-Competitive ,
Antitrust Provisions ,
Antitrust Violations ,
Appeals ,
Breach of Contract ,
Contract Disputes ,
Corporate Counsel ,
Exclusive Dealing Agreements ,
Federal Trade Commission (FTC) ,
FRAND ,
Intellectual Property Protection ,
IP License ,
Patents ,
Popular ,
Qualcomm ,
Royalties ,
Standard Essential Patents